1. Australia Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Identifai Fpo [id1]

Identifai Fpo [id1]

ID1.AX
Identifai Fpo [id1]AU flagAustralian Securities Exchange
0.50
AUD
+0.07
- -
95.03MMarket Cap
Identifai Fpo [id1]
ID1.AX
(Australian Securities Exchange)

Recent

price

0.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Satellos Bioscience Inc. (MSCLF)
Nordic Nanovector ASA (NANOV.OL)
Biosergen AB (BIOSGN.ST)
Aclaris Therapeutics, Inc. (0H8T.L)
Gelesis Holdings, Inc. (GLS-WT)
Dishman Carbogen Amcis Limited (DCAL.NS)
Business
Identifai Genetics Limited provides prenatal genetic screening through the application of genome-wide sequencing and artificial intelligence in Israel, the United States, Hong Kong, China, and Australia. The company's product, Windrose, is a first-trimester non-invasive prenatal test that provides cfDNA-based fetal risk assessment for more than 280 clinically actionable genes, all from a single blood draw and without requiring a partner sample. The company was founded in 2021 and is based in Subiaco, Australia.